ARS Pharmaceuticals Inc (SPRY): Nilai Total Aset Perusahaan

Logo grafis ARS Pharma (SPRY)

ARS Pharmaceuticals (SPRY) is implementing high-precision automated filling systems at partner sites, eliminating human error during sterile packaging. The compact spray format optimizes medication transport, reducing costs for delivery to pharmacies. Market price action on GURU.Markets shows total assets at 281.50, confirming the development of an emergency care ecosystem featuring unique needle-free technologies and a protected patent portfolio.

Total Aset Perusahaan ARS Pharmaceuticals (SPRY): kanggo periode 28.04.2023 - 28.10.2026

Rincian metrik komprehensif lan analitis ARS Pharma (SPRY)

- rega lan prakiraan konsensus rega:
Rega bursa ars-pharma.com|SPRY - Bagan rega target
- data kapitalisasi pasar:
Biji pasar ARS Corp|SPRY - Nilai Perusahaan
- data kapitalisasi buku:
Nilai Akuntansi Saham ARS Pharmaceuticals|SPRY - Kapitalisasi Buku|Rasio Kapitalisasi Pasar marang Nilai Buku ars-pharma.com|SPRY - Aset Agregat Perusahaan
- data utang lan likuiditas:
Rasio Kabeh Utang marang Dana Pribadi ARS Pharmaceuticals|SPRY - Utang jangka dawa marang ekuitas|Rasio utang jangka cendhak marang ekuitas ARS Corp|SPRY - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku ARS Corp|SPRY - Kewajiban jangka dawa perusahaan|Silihan lan utang jangka cendhak perusahaan ARS Pharmaceuticals
Pambiji fundamental:SPRY, ars-pharma.com
Produk dadi ARS Pharmaceuticals

Total assets reflect the aggregate value of business resources, calculated reverse-engineered via ROA to monitor capital efficiency and the risks of balance sheet inflation. By analyzing the assets of ARS Pharmaceuticals (SPRY) through ROA, an investor assesses the financial stability of ARS Pharmaceuticals during the implementation of an innovative nasal spray, which replaces injections and generates stable long-term demand for the drug.

Pesaing ARS Pharmaceuticals (SPRY)

HLN (haleon.com) - Aset Perusahaan|Aset Agregat Perusahaan Kenvue KVUE|Nilai Total Aset Perusahaan Verona Pharma PLC|Jyong Biotech Corp (MENS) - Total Aset Perusahaan|Nilai Agregat Aset Ligand Corp (LGND)|Total Aset Perusahaan AMRX (Amneal Pharmaceuticals)|perrigo.com - Total Aset Perusahaan|Aset Agregat Perusahaan Alvotech SA (ALVO)|LQDA: Nilai Agregat Aset|GLPG (Galapagos Genomics) - Aset Agregat Perusahaan|ANI Pharmaceuticals Corp (ANIP) - Gunggung Aset Perusahaan|MNKD (MannKind Corporation) - Total Aset Perusahaan|Total Aset Perusahaan amphastar.com (AMPH)|Pacira BioSciences, Inc. (PCRX) - Gunggung Aset Perusahaan|Nilai Agregat Aset TBPH (Theravance Biopharma Inc)|AQST: Aset Agregat Perusahaan|SCPH - Aset Perusahaan|Gunggung Aset Perusahaan Tectonic TECX|TNXP - Aset Agregat Bisnis|Total Aset Perusahaan sxtchina.com SXTC|Eupraxia Pharmaceuticals Inc. (EPRX) - Nilai Agregat Aset|Total Aset Perusahaan BHST (BioHarvest)|Aset Perusahaan EXOZ|Oramed Pharmaceuticals (ORMP) - Aset Agregat Perusahaan|Nilai Agregat Aset enterabio.com (ENTX)|Total Aset Perusahaan HYFT (MindWalk Holdings Inc.)|ABVC BioPharma Inc. - Total Aset Perusahaan|Aset Agregat Perusahaan Cumberland Pharma (CPIX)|QNTM: Nilai Agregat Aset|FibroGen, Inc. - Aset Agregat Perusahaan|Gunggung Aset Perusahaan telomirpharma.com|RANI - Gunggung Aset Perusahaan|Nilai Agregat Aset SNYR|RLYB - Aset Agregat Perusahaan|Nilai Total Aset Perusahaan lexariabioscience.com (LEXX)|Total Aset Perusahaan Pulmatrix, Inc.|Nilai Agregat Aset Pheton Holdings Limited PTHL|Aptorum - Total Aset Perusahaan|LYRA: Total Aset Perusahaan|Aset Agregat Perusahaan Impact BioMedical IBO|TNFA (TNF Pharmaceuticals, Inc.) - Nilai Agregat Aset|Aset Agregat Perusahaan YCBD|Gunggung Aset Perusahaan painreform.com|Total Aset Perusahaan CYTO|Total Aset Perusahaan Lipella Pharmaceuticals Inc (LIPO)|Optinose - Total Aset Perusahaan|Gunggung Aset Perusahaan Pieris Pharma PIRS|PROC (Procaps Group S.A.) - Total Aset Perusahaan|petrospharma.com (PTPI) - Aset Perusahaan|QLI: Gunggung Aset Perusahaan|Total Aset Perusahaan Acelyrin Inc.|TFF Pharma (TFFP) - Gunggung Aset Perusahaan